DEVELOPMENT OF ZOLMITRIPTAN MOUTH DISSOLVING FILMS: FORMULATION VARIABLES, MECHANICAL PROPERTIES, AND IN VITRO DRUG RELEASE STUDIES

  • SUDHIR MADDELA Department of Pharmacy, Krishna University, Machilipatnam – 521 001, Andhra Pradesh, India.
  • BUCHI N. NALLURI Siddhartha Pharma Innovation and Incubation Centre, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada – 520 010, Andhra Pradesh, India.

Abstract

Objective: The objective of the present investigation is to prepare zolmitriptan (ZOL) mouth dissolving films (MDFs) and to investigate the influence of formulation variables on physicomechanical, chemical, and drug release properties of the prepared MDFs.


Methods: The MDFs were prepared by solvent casting technique using wet film applicator. The impact of hydroxypropyl methylcellulose of different viscosity grades (hydroxy propyl methyl cellulose [HPMC] E3, E5, and E15), plasticizers (glycerol and polyethylene glycol [PEG]-400), and solubilizing agents (polyvinyl pyrrolidone [PVP K30] and sodium lauryl sulfate [SLS]) on physicomechanical, chemical, and drug release properties were evaluated. The MDFs were also characterized by Fourier-transform infrared spectroscopy, differential scanning calorimetry, and X-ray diffractometry studies.


Results: The MDFs prepared were transparent and smooth and showed no recrystallization. The tensile strength of the MDFs increased significantly with an increase in polymer viscosities, and about a 2.63-fold increase in tensile strength was observed for HPMC E15 MDFs compared to E3, whereas an increase in film thickness resulted in brittle MDFs with low tensile strength. Similar results were observed with percent elongation and folding endurance of the MDFs. In vitro, drug release studies indicate that higher film thickness and polymer viscosities delayed the MDF disintegration and, in turn, the ZOL release. Addition of PVP K30 and SLS to HPMC E3 formulations resulted in 1.66- and 1.53-fold increase in ZOL release rates.


Conclusion: Overall, F7 formulation showed quicker disintegration (within 11 s) and ZOL release rates (within 180 s) along with good physicomechanical properties. These results indicated that the disintegration and drug release of ZOL can be enhanced to a greater extent by optimizing formulation variables in MDFs.

Keywords: Formulation variables, Mouth dissolving films, Tensile strength, Wet film applicator, Zolmitriptan.

References

1. Lopez FL, Ernest TB, Tule C, Gull MO. Formulation approaches to paediatric oral drug delivery: Benefits and limitations of current platforms. Expert Opin Drug Deliv 2015;12:1727-40.
2. Ivanovska V, Rademaker CM, Van Dig KL, Teeuwisse AK. Paediatric drug formulations: A review of challenges and progress. Paediatrics 2014;134:361-72.
3. Parul S, Anoop K, Pankaj S, Sharad V. Fast disintegrating oral films: A recent trend of drug delivery. Int J Drug Dev Res 2012;4:80-94.
4. Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery: A review. Pharm Sci Tech Today 2000;3:138-45.
5. Arun A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: An innovative drug delivery system and dosage form. Int J Chem Tech Res 2010;2:576-83.
6. Dixit AS, Kulakarni PK, Reddy SC. Methotrexate fast disintegrating tablet as a dosage form for dysphagia patients. Int J Pharm Pharm Sci 2014;6:217-5.
7. Desu P, Sahu M. Formulation and evaluation of fast dissolving films of zolmitriptan. Int Res J Pharm 2012;3:373-76.
8. Natarajan R, Sravanthi CH, Saranya V, Rajendran NN. Effect of super disintegrants on oral disintegrating tablets of zolmitriptan. Int J Pharm Ind Res 2014;4:57-62.
9. Hirokazu O, Hirohisa T, Kotaro I, Kazumi D. Development of polymer film dosage form of lidocaine for buccal administration. J Controll Release 2001;77:253-60.
10. Nair AB, Kumria R, Harsha S, Mahesh A, Bandar E, Alhaider IA. In vitro techniques to evaluate buccal films. J Controll Release 2013;116:10-21.
11. Garsuch V, Breitkreutz J. Comparitive investigations on different polymers for the preparation of fast-dissolving oral films. J Pharm Pharm 2010;62:539-45.
12. El-Setouhy DA, El-Malak NS. Formulation of a novel tianeptine sodium orodispersible film. AAPS Pharm Sci Tech 2010;11:1018-25.
13. Gavaskar B, Kumar SV, Sharan G, Madhusudan Y. Overview on fast dissolving films. Int J Pharm Pharm Sci 2010;2:29-33.
14. Okamoto H, Taguchi H, Iida K, Danjo K. Development of polymer film dosage forms of lidocaine for buccal administration. I. Penetration rate and release rate. J Control Release 2001;77:253-60.
15. Lai KL, Yuan F, Hao H, Li Q, Shuai Z, Li HY, et al. Orally dissolving film for sublingual and buccal delivery of ropinrole. Colloids Surf B 2018;163:9-18.
16. Takeuchi Y, Umemura K, Tahara K, Takeuchi H. Formulation design of hydroxypropyl cellulose films for use as orally disintegrating dosage forms. J Drug Deliv Sci Tech 2018;46:93-100.
17. Lapidus H, Lordi NG. Drug release from compressed hydrophilic matrices. J Pharm Sci 1996;55:840-3.
18. Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-8.
Statistics
36 Views | 16 Downloads
How to Cite
SUDHIR MADDELA, and BUCHI N. NALLURI. “DEVELOPMENT OF ZOLMITRIPTAN MOUTH DISSOLVING FILMS: FORMULATION VARIABLES, MECHANICAL PROPERTIES, AND IN VITRO DRUG RELEASE STUDIES”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 4, Mar. 2019, pp. 273-9, https://innovareacademics.in/journals/index.php/ajpcr/article/view/32176.
Section
Original Article(s)